Fundraising FoximBio
Minneapolis, US · Michigan LLC · 1 known investors
Find your way into imBio
Sign up to see every warm intro you have to imBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the imBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DH
David HannesExecutiveDavid Hannes brings two decades of experience in commercial, service, and operations leadership at medical device companies ranging from early-stage to Fortune 50 firms. He has led both new business development and performance improvements for established organizations.
TD
Troy D. KopischkeExecutive
CM
Cynthia MaierExecutive
MS
Mark SylvesterExecutive
DJ
Danny J. CunaginExecutive
AR
Alnawaz Rehemtulla, M.D.Named on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2015
▶$1.1MraisedSep 2015 · 1 investors · Other TechnologyRule 506(b)
▶$1.1MraisedSep 2015 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alnawaz Rehemtulla, M.D.Director
- David HannesExecutive Officer
- Troy D. KopischkeExecutive Officer, Director
- Cynthia MaierExecutive Officer, Director
- Mark SylvesterExecutive Officer
- Danny J. CunaginExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Michigan
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Inari Medical Inc.Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
GlobaldataGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Companies working in the same space as imBio.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $251.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $166.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $222.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $179.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $150.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $144.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are imBio's investors?
- imBio's investors include Seneca Partners.
- How much funding has imBio raised?
- imBio has disclosed $1.1M raised across 1 round.
- Where is imBio headquartered?
- imBio is headquartered in Minneapolis, US.